The social and economic burden of brain-related disorders is larger than that of cancer and cardiac disease combined. While neuromodulation has been proven to be effective at the research level to treat many neurological, psychiatric and sensory conditions,  commercial neuromodulation devices offer relatively poor longevity and limited rates of efficacy.

In particular, Epilepsy is one of the most common neurological conditions, affecting approximately 1% of the world population.  For 1/3 of patients, the drugs are not effective. It has been medically proven that surgery is the best option for most of these patients.  Only 3,000 epilepsy surgeries are conducted each year in the US, representing 0.1% of epilepsy sufferers.  One of the reasons for the low surgical uptake is the lack of high quality date available from the legacy sensor technology.  In addition, 25% of patients who start the diagnostic process do not proceed to surgery, partly due to risky surgeries or patients declining.

Epilepsy patients undergo intra-cranial monitoring as part of the protocol for surgical resection of brain tissue to treat seizures.  These patients are often therefore the subjects of research into the electrical workings of the brain.

Intra-Cortical Electrodes

Neuraura’s intra-cranial electrodes include:

  • Cortical electrodes: grid and strip electrodes

  • Subdural electrodes: depth electrodes for use with anchor bolts for stereo-EEG

  • Hybrid electrodes: novel proprietary design combining cortical micro-strips with depth electrode


Neuraura’s electrodes will improve patient outcomes, reduce clinician burden and reduce healthcare system costs:

  • Lower re-occurrence of seizures due to more accurate pin-pointing of seizure foci, including more “natural” seizure data from less stressed patients

  • Less brain tissue removed due to improved clinician confidence with better quality data

  • Lower risk of bleeding / infection due to minimized invasiveness with equivalent brain coverage with 5-8 burr holes versus 15-18 (hybrid electrodes)

  • Shortened surgery times with 5-8 burr replacing invasive craniotomy (hybrid electrodes)


Wireless EEG Monitoring

Neuraura’s wireless EEG will improve patient experience and outcomes, enable ambulatory care either within a hospital or potentially at home, reduce clinician burden and reduce healthcare system costs:

  • Less tortuous experience through ambulatory care in-hospital enabled by wireless EEG system

  • Improved patient compliance to diagnostic monitoring due to improved experience

  • Shorter recovery in hospital and at home as a result of ambulatory care enabled by wireless EEG system

  • Reduced costs due to reduced length of hospital stay for recovery

  • Reduced costs with potential to send some patients home for monitoring process in future

eeg front.png
eeg back.png
eeg on.png

Data Visualization

Neuraura’s visualization software will encompass both traditional EEG trace visualization and a 3D map of the patient’s brain which combines the EEG and MRI data sets.

Neuraura’s data visualization will reduce clinician burden as a results of fewer clinician hours to review data due to improved fidelity and 3D visualization of patient's brain .The unique electrophysiological data set captured from epilepsy patients will help inform future improvements in epilepsy diagnosis and treatment and broader neuromodulation applications.

DISCLAIMER: The information herein is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. Neuraura Biotech Inc., makes no representation and assumes no responsibility for the accuracy of information contained on or available through this web site, and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources, and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED HEREIN. Neuraura Biotech Inc., does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific tests, products, procedures, treatments, services, opinions, health care providers or other information that may be contained on or available herein.

Thanks for subscribing !

N for Neuraura.png

Calgary, Canada   |   Melbourne, Australia

  • LinkedIn Social Icon
  • Twitter

Copyright © 2020 by Neuraura Biotech Inc. - All Right Reserved